Back

What can we learn from COAPT trial?

26 May 2019 (09:00 - 09:15)
Organised by:
Congress Presentation Part of: Functional mitral regurgitation: the road ahead. Valvular Heart Disease HFA Premium Access Heart Failure 2019

About the speaker

Photo
Professor Joann Lindenfeld

Vanderbilt University, Nashville (United States of America)

4 More presentations in this session

Presentation thumbnail
Transcatheter mitral interventions: indications and controversies.
Professor P. Ponikowski (Wroclaw, PL)
Slides Video
Presentation thumbnail
MITRA-FR trial: facts and perspectives.
Professor N. Mewton (Lyon, FR)
Slides Video
Presentation thumbnail
Therapeutic synergy between drugs, devices and interventions.
Professor F. Ruschitzka (Zurich, CH)
Slides Video
Presentation thumbnail
Panel discussion: the road ahead.
Video

Access the full session

Session thumbnail
Functional mitral regurgitation: the road ahead.

The Event

Event poster

Heart Failure 2019

26 May 2019 09:00 CET
You may be interested in
thumbnail
Congress Presentation
Cardiovascular outcomes in a real-world edge to edge mitral valve repair series in a single center: impact of echocardiographic COAPT-like characteristics
29 June 2021
thumbnail
Congress Session
Treatment of cardiovascular comorbidities in patients with heart failure
17 May 2025
thumbnail
Congress Presentation
Maximally tolerated guideline-directed medical therapy and barriers to optimization in patients with heart failure with reduced ejection fraction: The COAPT trial
28 August 2022
thumbnail
Congress Presentation
Cardiac dysfunction rather than aortic valve stenosis severity drives exercise intolerance and adverse hemodynamics
10 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources